Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday

Pharma, banking funds top mutual fund gainers in March

Pharma, banking funds top mutual fund gainers in March
Comment E-mail Print Share
First Published: Mon, Apr 05 2010. 02 33 PM IST
Updated: Mon, Apr 05 2010. 02 33 PM IST
New Delhi: Sectoral funds investing in pharma and banks topped the performance charts among Indian equity funds in March, while diversified stock plans lagged due to high exposure to cash and sectors like capital goods.
Pharma funds on an average returned 10.8% during the month while financial services funds earned 7.9%, data from fund tracker Lipper, a Thomson Reuters company, showed, higher than the 6.7% gain in the benchmark index.
“The passage of US healthcare bill would benefit Indian drug companies ? this helped pharmaceutical stocks and in turn funds,” said Chintamani Dagade, senior research analyst at Morningstar India.
Financial firms, the most favoured sector of money managers in India, did well on improving credit outlook, analysts said.
The BSE Banking index gained 8.4% in the month with large private lenders like ICICI and HDFC Bank gaining 9.27 and 13.36%, respectively.
“The outlook for credit growth is definitely far better than what the actual growth has been for last year,” said Vetri Subramaniam, head of equities at Religare Asset Management, whose Religare Banking Fund was the category’s best performer in March.
“In an overall sense that should be positive for the banking sector,” he added.
Actively managed equity diversified funds, the biggest category of stock funds in India by number and assets, recorded a 6.05% growth in unit values, mildly underperforming the benchmark index.
Higher allocation to sectors like technology and capital goods and a near 7% exposure to cash hampered the performance of these funds, experts said.
The BSE IT index rose 1.2%, while the capital goods index gained 4.5% in March.
These two sectors collectively accounted for nearly 20% of such funds’ equity investments at the end of February, data from fund tracker ICRA Online showed.
Bond, Gold funds
Indian fixed income funds that invest in government securities, which lost 0.2% in February, made a comeback in March by gaining 0.65%.
The 10-year federal bond yield did not change much on a month-on-month basis, but fell to their lowest in seven weeks on March 30 after a lower-than-expected government borrowing schedule for the six months beginning April.
“Investors also used lower prices as an opportunity to invest in market,” Dagade of Morningstar India said.
India’s central bank raised both its key short-term rates by 25 basis points each on 19 March, citing intensifying inflationary pressures and a steady economic recovery.
India’s gold exchange traded funds (ETFs) lost 2.46% during the month as a strong dollar overseas reduced the precious metal’s appeal as an alternative investment.
On the continuous charts, gold futures ended March at Rs16,295 per 10 grams, down nearly 3% during the month.
Comment E-mail Print Share
First Published: Mon, Apr 05 2010. 02 33 PM IST
More Topics: India | Funds | Pharma | Lipper | Morningstar India |